| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |